cough - Nursing Case Study
Pathophysiology
• Primary mechanism: Irritation of Cough Receptors - Located in the respiratory tract, these receptors are activated by irritants (e.g., mucus, foreign particles, inflammation) triggering the cough reflex via the vagus nerve to expel the irritant.
• Secondary mechanism: Neural Reflex Arc - The signal travels to the brain's cough center (medulla), which coordinates the contraction of respiratory muscles, producing a forceful expulsion of air to clear the airway.
• Key complication: Persistent Cough - Chronic stimulation of cough receptors can lead to airway inflammation and damage, potentially causing or exacerbating conditions like asthma or chronic bronchitis, impacting patient quality of life.
Patient Profile
Demographics:
35-year-old male, construction worker
History:
• Key past medical history: Asthma since childhood, seasonal allergies
• Current medications: Albuterol inhaler as needed, loratadine 10 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent cough lasting two weeks
• Key symptoms: Productive cough with greenish sputum, mild chest discomfort, shortness of breath on exertion, intermittent fever
• Vital signs: Temperature 100.4°F, heart rate 92 bpm, respiratory rate 22 breaths per minute, blood pressure 132/84 mmHg, oxygen saturation 93% on room air
Section 1
As the clinical team further evaluates the 35-year-old patient, new diagnostic results reveal some concerning findings. A chest X-ray shows signs of patchy infiltrates in the right lower lobe, suggesting a possible bacterial infection contributing to the persistent cough and fever. Additionally, a sputum culture has been obtained, which preliminarily indicates the presence of a bacterial pathogen, pending full identification and sensitivity results. Blood tests reveal an elevated white blood cell count of 14,500/mm³, indicating a systemic inflammatory response, likely due to an infection. Given the patient's history of asthma, this respiratory infection could potentially exacerbate his underlying condition, leading to increased airway reactivity and further complicating his respiratory status.
In light of these findings, the medical team decides to initiate treatment with a broad-spectrum antibiotic, mindful of the patient's penicillin allergy. Azithromycin is chosen as an appropriate alternative, aiming to target the most likely respiratory pathogens while awaiting specific culture results. The patient's albuterol inhaler usage is also reviewed, and a short course of oral corticosteroids is considered to address any potential asthma exacerbation. The clinical team closely monitors the patient's response to these interventions, particularly focusing on improvements in oxygen saturation and respiratory effort.
However, within 48 hours of starting treatment, the patient experiences a change in status. His oxygen saturation drops to 90% on exertion, and he reports increased shortness of breath and fatigue. These developments necessitate a careful reassessment of his condition, including a repeat chest X-ray and further laboratory testing, to ensure that the current treatment approach is effective or if adjustments are needed. The possibility of complications like pneumonia or an asthma exacerbation prompts the team to enhance supportive care measures, such as supplemental oxygen and intensified bronchodilator therapy, highlighting the dynamic nature of his clinical management.
Section 2
The clinical team conducts a thorough reassessment of the patient's current condition, focusing on his respiratory status and overall clinical picture. Upon initial assessment, the patient's vital signs reveal a blood pressure of 130/85 mmHg, a heart rate of 105 beats per minute, and a respiratory rate of 22 breaths per minute, with an oxygen saturation of 92% on room air. During auscultation, diminished breath sounds are noted in the right lower lobe, accompanied by coarse crackles, suggesting localized consolidation. The patient continues to report increased fatigue and exertional dyspnea, which are concerning for a potential progression of the underlying infection or an asthma exacerbation.
In response to these findings, the clinical team orders a repeat chest X-ray and additional laboratory tests, including arterial blood gases (ABGs) to assess the patient's oxygenation and acid-base status. The chest X-ray reveals an increase in the density of the infiltrates in the right lower lobe, consistent with worsening pneumonia. The ABG results show a pH of 7.35, a PaCO2 of 47 mmHg, and a PaO2 of 68 mmHg, indicating respiratory acidosis and hypoxemia. These results suggest that the patient's respiratory function is deteriorating, necessitating immediate adjustments to his management plan to prevent further complications.
Given these developments, the team decides to escalate supportive care measures. The patient is started on supplemental oxygen via nasal cannula to maintain oxygen saturation above 94%, and his bronchodilator therapy is intensified with more frequent dosing of albuterol. The team also considers adding a long-acting beta-agonist to improve asthma control. In light of the potential for resistant organisms, the antibiotic regimen is reviewed, and the team awaits the full sputum culture and sensitivity results to potentially tailor the antibiotic therapy. Close monitoring of the patient's response to these interventions is critical, as the team remains vigilant for any signs of further decompensation or the emergence of additional complications.
Section 3
As the clinical team continues to monitor the patient closely, they observe a change in his status over the next 24 hours. Despite the implementation of supplemental oxygen and intensified bronchodilator therapy, his oxygen saturation remains marginally stable around 93% with nasal cannula support. However, his respiratory rate has increased to 28 breaths per minute, and he appears more tachypneic and uncomfortable. The patient reports increased chest tightness and is visibly anxious, indicating possible worsening of his respiratory condition or the onset of a new complication.
A repeat arterial blood gas shows a pH of 7.32, a PaCO2 of 50 mmHg, and a PaO2 of 65 mmHg, confirming worsening respiratory acidosis and persistent hypoxemia. These findings, coupled with the clinical presentation, suggest that the patient is not adequately ventilating, potentially due to either progressive pneumonia or an exacerbation of underlying asthma that has not responded adequately to the current therapy. This prompts the clinical team to consider the need for non-invasive ventilation to improve alveolar ventilation and correct the acid-base imbalance.
In response to the patient's deteriorating condition, the team opts to initiate bi-level positive airway pressure (BiPAP) therapy to support his ventilation and improve gas exchange. They also review the need for potential corticosteroid therapy to reduce airway inflammation, which could be contributing to the increased respiratory distress. Additionally, pending results from the sputum culture and sensitivity may necessitate a change in the antibiotic regimen if resistant organisms are identified. The team remains vigilant, ready to escalate care, including possible transition to intensive care, should the patient's status not improve with these interventions.
Section 4
As BiPAP therapy is initiated, the clinical team closely monitors the patient's response to the intervention. Over the next few hours, there is a modest improvement in his respiratory rate, which decreases to 24 breaths per minute, and his oxygen saturation increases to 95% on BiPAP support. Despite these improvements, the patient continues to report significant chest tightness and remains visibly anxious. A follow-up assessment reveals diminished breath sounds in the right lower lobe, prompting consideration of atelectasis or a pleural effusion as potential new complications.
To investigate further, a chest X-ray is obtained, revealing a new right-sided pleural effusion with associated atelectasis. This new finding suggests that fluid accumulation may be contributing to the patient's respiratory distress and ineffective ventilation. The team contemplates the necessity of a thoracentesis to relieve the effusion and improve lung expansion. Meanwhile, corticosteroid therapy is initiated to address potential underlying inflammatory processes and further enhance respiratory function.
While awaiting the results of the sputum culture and sensitivity, which will guide any necessary changes in antibiotic therapy, the patient's condition is closely monitored for any signs of further decompensation. The healthcare team prepares for possible escalation of care, maintaining readiness for a consult with the intensive care team should the patient's respiratory status fail to improve with current interventions. This vigilant approach ensures that any new complications are promptly identified and addressed, providing the best chance for the patient's recovery.
Section 5
After initiating corticosteroid therapy and considering thoracentesis for the pleural effusion, the clinical team continues to closely monitor the patient's response to these interventions. Over the next several hours, the patient's respiratory status shows slight improvement; the respiratory rate stabilizes at 22 breaths per minute, and the patient reports a mild reduction in chest tightness. However, his anxiety persists, and he expresses difficulty sleeping due to discomfort and concern about his breathing. Vital signs reveal a heart rate of 110 beats per minute and blood pressure of 140/85 mmHg, indicating mild tachycardia and hypertension, possibly related to anxiety or as a side effect of steroid therapy. Oxygen saturation remains stable at 95% on BiPAP.
The team notices that despite the stabilization in respiratory parameters, the patient begins to exhibit a low-grade fever, with a temperature of 100.8°F. This new development prompts consideration of an infectious process or inflammatory response as a contributing factor to his condition. A complete blood count (CBC) shows a white blood cell count of 13,000 cells/mcL, suggesting a possible underlying infection or stress response. Additionally, the patient reports increased sputum production, which is now tinged with a yellow-green hue, raising concerns about a potential bacterial infection exacerbating his respiratory issues.
Given these findings, the healthcare team decides to expedite the thoracentesis to relieve the pleural effusion and send pleural fluid for analysis, which may provide critical insights into the cause of the effusion and guide further treatment. Meanwhile, empirical broad-spectrum antibiotics are initiated while awaiting sputum culture results, ensuring a comprehensive approach to managing possible infection. The team remains vigilant, ready to escalate care if the patient's condition worsens, and continues to emphasize effective communication and support to alleviate his anxiety and enhance overall recovery efforts.